What Researchers Did
Researchers conducted a systematic review and meta-analysis to compare hyperbaric oxygen therapy with standard care in adults with Fournier's gangrene.
What They Found
The meta-analysis of thirteen retrospective studies, involving 322 patients treated with hyperbaric oxygen therapy and 366 controls, found a significantly lower mortality rate in the hyperbaric oxygen therapy group. However, secondary outcomes such as hospital length of stay and number of debridements did not show significant differences between groups.
What This Means for Canadian Patients
Canadian patients with Fournier's gangrene might benefit from hyperbaric oxygen therapy as an adjunctive treatment, potentially leading to improved survival rates. This therapy could be considered alongside standard care to enhance patient outcomes.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The findings are primarily based on retrospective studies, which may introduce biases and limit the overall strength of the evidence.